{"disease":{"id":"lungcancer","name":"lungcancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03114319","title":"Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":227,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT02285426","title":"HD+ I-scan Bronchoscopy Vascular Abnormalities Detection Multicenter Study","phase":"","overall_status":"COMPLETED","enrollment_count":134,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT03020251","title":"Effects of Preoperative Rehabilitation in Patients Resected for Lung Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Centre Jean Perrin","has_results":false},{"nct_id":"NCT02185690","title":"A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"University Health Network, Toronto","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}